NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare skin disorder: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called BCX17725 in healthy people and those with Netherton syndrome, a rare genetic skin condition causing severe redness and scaling. The main goals are to check safety and how the body processes the drug. In later parts, researchers will …
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New cream shows promise for rare skin disorder
Symptom relief Recruiting nowThis early-stage study tests a new cream called ATR12-351 in 12 adults with Netherton Syndrome, a rare genetic skin condition. The cream is applied to skin lesions twice daily for two weeks, with a placebo cream used on other areas for comparison. The main goals are to check safe…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC